Explore Every Angle

Thoroughly researched perspectives and commentary on the trends shaping global markets. Subscribe to Updates →

Arelis “Lis” Agosto

Arelis (Lis) started with Global X in 2022 as a Research Analyst covering healthcare-related funds in the Thematic Growth suite of ETFs. Prior to joining Global X, she worked as a Senior Healthcare Analyst at Third Bridge, covering US life sciences, diagnostics, biotech, pharmaceutical services, and animal health. Lis holds a BA from Babson College in Business, with a concentration in Global Businesses Management. She is a native speaker of both English and Spanish.

ASCO Annual Meeting 2022: An Innovation Showcase in Cancer Treatment

Editor’s Note: Please hover over the terms highlighted in sea green for their definitions. The glossary at the end also includes these in ... By Arelis Agosto

Liquid Biopsy: A Pathway to Earlier and Less Invasive Cancer Detection

Editor’s Note: Hover over terms in sea green for a pop-out glossary definition. Full glossary also included at the end with terms listed in ... By Arelis Agosto

Four Genomic Companies with Upcoming Catalysts

Patience can be a virtue in the genomic space, as next-generation biotech treatments don’t hit the market overnight. However, when all the ... By Arelis Agosto

Telemedicine: Rewriting Healthcare Standards as New Policies Emerge

A look at ongoing legislative policy and its expected impact on the Telemedicine & Digital Health space. By Arelis Agosto

There are no articles available.

Investing involves risk, including the possible loss of principal. Diversification does not ensure a profit or guarantee against a loss. This information is not intended to be individual or personalized investment or tax advice and should not be used for trading purposes. Please consult a financial advisor or tax professional for more information regarding your investment and/or tax situation.